BindingDB logo
myBDB logout

BDBM296344 4-(6-(4-((6- methoxypyridin- 3- yl)methyl) piperazin-1- yl)pyridin-3- yl)-6- (neopentyloxy) pyrazolo[1,5- a]pyridine-3- carbonitrile::US10112942, Example 77::US10137124, Example 77::US10172851, Example 77::US10555944, Example 77

SMILES: COc1ccc(CN2CCN(CC2)c2ccc(cn2)-c2cc(OCC(C)(C)C)cn3ncc(C#N)c23)cn1

InChI Key: InChIKey=LXFCOPXVLIKHAD-UHFFFAOYSA-N

Data: 8 IC50

Find this compound or compounds like it in BindingDB or PDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 8 hits for monomerid = 296344   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kcal/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Proto-oncogene tyrosine-protein kinase receptor Ret


(Homo sapiens (Human))
BDBM296344
PNG
(4-(6-(4-((6- methoxypyridin- 3- yl)methyl) piperaz...)
Show SMILES COc1ccc(CN2CCN(CC2)c2ccc(cn2)-c2cc(OCC(C)(C)C)cn3ncc(C#N)c23)cn1
Show InChI InChI=1S/C29H33N7O2/c1-29(2,3)20-38-24-13-25(28-23(14-30)17-33-36(28)19-24)22-6-7-26(31-16-22)35-11-9-34(10-12-35)18-21-5-8-27(37-4)32-15-21/h5-8,13,15-17,19H,9-12,18,20H2,1-4H3
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 277n/an/an/an/a7.4n/a



Array BioPharma Inc

US Patent


Assay Description
Compounds of Formula I were screened for their ability to inhibit wildtype and V804M mutant RET kinase using CisBio's HTRF® KinEASE¿-TK assay tec...


US Patent US10112942 (2018)


BindingDB Entry DOI: 10.7270/Q2S75JB5
More data for this
Ligand-Target Pair
RET kinase mutant (V804M)


(Homo sapiens (Human))
BDBM296344
PNG
(4-(6-(4-((6- methoxypyridin- 3- yl)methyl) piperaz...)
Show SMILES COc1ccc(CN2CCN(CC2)c2ccc(cn2)-c2cc(OCC(C)(C)C)cn3ncc(C#N)c23)cn1
Show InChI InChI=1S/C29H33N7O2/c1-29(2,3)20-38-24-13-25(28-23(14-30)17-33-36(28)19-24)22-6-7-26(31-16-22)35-11-9-34(10-12-35)18-21-5-8-27(37-4)32-15-21/h5-8,13,15-17,19H,9-12,18,20H2,1-4H3
PDB

GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 1.13E+3n/an/an/an/an/an/a



Array BioPharma Inc

US Patent




US Patent US10112942 (2018)


BindingDB Entry DOI: 10.7270/Q2S75JB5
More data for this
Ligand-Target Pair
Proto-oncogene tyrosine-protein kinase receptor Ret


(Homo sapiens (Human))
BDBM296344
PNG
(4-(6-(4-((6- methoxypyridin- 3- yl)methyl) piperaz...)
Show SMILES COc1ccc(CN2CCN(CC2)c2ccc(cn2)-c2cc(OCC(C)(C)C)cn3ncc(C#N)c23)cn1
Show InChI InChI=1S/C29H33N7O2/c1-29(2,3)20-38-24-13-25(28-23(14-30)17-33-36(28)19-24)22-6-7-26(31-16-22)35-11-9-34(10-12-35)18-21-5-8-27(37-4)32-15-21/h5-8,13,15-17,19H,9-12,18,20H2,1-4H3
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 277n/an/an/an/an/an/a



Array BioPharma Inc

US Patent


Assay Description
Compounds of Formula I were screened for their ability to inhibit wildtype and V804M mutant RET kinase using CisBio's HTRF® KinEASE¿-TK assay tec...


US Patent US10137124 (2018)


BindingDB Entry DOI: 10.7270/Q28S4RZ6
More data for this
Ligand-Target Pair
RET Kinase (V804M) (aa658-end)


(Homo sapiens (Human))
BDBM296344
PNG
(4-(6-(4-((6- methoxypyridin- 3- yl)methyl) piperaz...)
Show SMILES COc1ccc(CN2CCN(CC2)c2ccc(cn2)-c2cc(OCC(C)(C)C)cn3ncc(C#N)c23)cn1
Show InChI InChI=1S/C29H33N7O2/c1-29(2,3)20-38-24-13-25(28-23(14-30)17-33-36(28)19-24)22-6-7-26(31-16-22)35-11-9-34(10-12-35)18-21-5-8-27(37-4)32-15-21/h5-8,13,15-17,19H,9-12,18,20H2,1-4H3
PDB

GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 1.13E+3n/an/an/an/an/an/a



Eli Lilly and Company

US Patent


Assay Description
Compounds of Formula I were screened for their ability to inhibit wildtype and V804M mutant RET kinase using CisBio's HTRF KinEASE-TK assay techn...


US Patent US10555944 (2020)


BindingDB Entry DOI: 10.7270/Q279473N
More data for this
Ligand-Target Pair
RET Kinase (aa658-end)


(Homo sapiens (Human))
BDBM296344
PNG
(4-(6-(4-((6- methoxypyridin- 3- yl)methyl) piperaz...)
Show SMILES COc1ccc(CN2CCN(CC2)c2ccc(cn2)-c2cc(OCC(C)(C)C)cn3ncc(C#N)c23)cn1
Show InChI InChI=1S/C29H33N7O2/c1-29(2,3)20-38-24-13-25(28-23(14-30)17-33-36(28)19-24)22-6-7-26(31-16-22)35-11-9-34(10-12-35)18-21-5-8-27(37-4)32-15-21/h5-8,13,15-17,19H,9-12,18,20H2,1-4H3
PDB

GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 277n/an/an/an/an/an/a



Array BioPharma Inc

US Patent


Assay Description
Compounds of Formula I were screened for their ability to inhibit wildtype and V804M mutant RET kinase using CisBio's HTRF KinEASE -TK assay tech...


US Patent US10172851 (2019)


BindingDB Entry DOI: 10.7270/Q2GM89CV
More data for this
Ligand-Target Pair
RET Kinase (V804M) (aa658-end)


(Homo sapiens (Human))
BDBM296344
PNG
(4-(6-(4-((6- methoxypyridin- 3- yl)methyl) piperaz...)
Show SMILES COc1ccc(CN2CCN(CC2)c2ccc(cn2)-c2cc(OCC(C)(C)C)cn3ncc(C#N)c23)cn1
Show InChI InChI=1S/C29H33N7O2/c1-29(2,3)20-38-24-13-25(28-23(14-30)17-33-36(28)19-24)22-6-7-26(31-16-22)35-11-9-34(10-12-35)18-21-5-8-27(37-4)32-15-21/h5-8,13,15-17,19H,9-12,18,20H2,1-4H3
PDB

GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 1.13E+3n/an/an/an/an/an/a



Array BioPharma Inc

US Patent


Assay Description
Compounds of Formula I were screened for their ability to inhibit wildtype and V804M mutant RET kinase using CisBio's HTRF KinEASE -TK assay tech...


US Patent US10172851 (2019)


BindingDB Entry DOI: 10.7270/Q2GM89CV
More data for this
Ligand-Target Pair
RET Kinase (aa658-end)


(Homo sapiens (Human))
BDBM296344
PNG
(4-(6-(4-((6- methoxypyridin- 3- yl)methyl) piperaz...)
Show SMILES COc1ccc(CN2CCN(CC2)c2ccc(cn2)-c2cc(OCC(C)(C)C)cn3ncc(C#N)c23)cn1
Show InChI InChI=1S/C29H33N7O2/c1-29(2,3)20-38-24-13-25(28-23(14-30)17-33-36(28)19-24)22-6-7-26(31-16-22)35-11-9-34(10-12-35)18-21-5-8-27(37-4)32-15-21/h5-8,13,15-17,19H,9-12,18,20H2,1-4H3
PDB

GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 277n/an/an/an/an/an/a



Eli Lilly and Company

US Patent


Assay Description
Compounds of Formula I were screened for their ability to inhibit wildtype and V804M mutant RET kinase using CisBio's HTRF KinEASE-TK assay techn...


US Patent US10555944 (2020)


BindingDB Entry DOI: 10.7270/Q279473N
More data for this
Ligand-Target Pair
RET kinase mutant (V804M)


(Homo sapiens (Human))
BDBM296344
PNG
(4-(6-(4-((6- methoxypyridin- 3- yl)methyl) piperaz...)
Show SMILES COc1ccc(CN2CCN(CC2)c2ccc(cn2)-c2cc(OCC(C)(C)C)cn3ncc(C#N)c23)cn1
Show InChI InChI=1S/C29H33N7O2/c1-29(2,3)20-38-24-13-25(28-23(14-30)17-33-36(28)19-24)22-6-7-26(31-16-22)35-11-9-34(10-12-35)18-21-5-8-27(37-4)32-15-21/h5-8,13,15-17,19H,9-12,18,20H2,1-4H3
PDB

GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 1.13E+3n/an/an/an/an/an/a



Array BioPharma Inc

US Patent


Assay Description
Compounds of Formula I were screened for their ability to inhibit wildtype and V804M mutant RET kinase using CisBio's HTRF® KinEASE¿-TK assay tec...


US Patent US10137124 (2018)


BindingDB Entry DOI: 10.7270/Q28S4RZ6
More data for this
Ligand-Target Pair